Jianhui Wu Selected Research

Apolipoproteins E (ApoE)

9/2020	[Clinical investigation on the related factors for the application of systemic glucocorticoids in patients with acute exacerbation of chronic obstructive pulmonary disease with carbon dioxide retention].
3/2020	The value of apolipoprotein E in distinguishing benign and malignant unilateral pleural effusions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianhui Wu Research Topics

Disease

49	Neoplasms (Cancer) 03/2023 - 10/2009
17	Thrombosis (Thrombus) 01/2020 - 01/2011
13	Inflammation (Inflammations) 01/2022 - 03/2010
8	Carcinogenesis 04/2022 - 01/2014
7	Chronic Obstructive Pulmonary Disease (COPD) 10/2023 - 01/2020
7	Edema (Dropsy) 01/2020 - 03/2010
6	Infections 12/2022 - 07/2015
6	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2014
5	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 03/2010
5	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2023 - 01/2020
5	Hyperplasia 11/2023 - 09/2017
5	Nasopharyngeal Carcinoma 12/2020 - 03/2010
5	Carcinoma (Carcinomatosis) 07/2018 - 03/2010
4	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 01/2022
4	Retroperitoneal liposarcoma 04/2024 - 10/2019
4	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 10/2017
3	Pneumonia (Pneumonitis) 05/2023 - 09/2020
3	Body Weight (Weight, Body) 12/2021 - 01/2017
3	Squamous Cell Carcinoma of Head and Neck 01/2019 - 01/2014
2	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2014
2	Hypertension (High Blood Pressure) 04/2024 - 01/2023
2	Occupational Stress 01/2024 - 01/2023
2	Obesity 01/2024 - 01/2022
2	Pleural Effusion (Pleural Effusions) 05/2023 - 03/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2023 - 01/2016
2	Hyperuricemia 01/2023 - 01/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2019
2	Abscess 03/2022 - 05/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 01/2021
2	Heart Failure 01/2022 - 09/2020
2	Hypoxia (Hypoxemia) 05/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2019
2	Liposarcoma 01/2021 - 01/2020
2	Urinary Bladder Neoplasms (Bladder Cancer) 09/2019 - 05/2019
2	Breast Neoplasms (Breast Cancer) 12/2018 - 03/2010
2	Hemorrhage 01/2018 - 12/2011
2	Chronic Pain 09/2011 - 03/2010

Drug/Important Bio-Agent (IBA)

11	AcidsIBA 01/2019 - 10/2009
10	P-SelectinIBA 01/2020 - 10/2012
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2018
8	Long Noncoding RNAIBA 06/2021 - 07/2017
8	Interleukin-8 (Interleukin 8)IBA 01/2020 - 03/2015
6	Xylenes (Xylene)IBA 01/2020 - 03/2010
5	Immune Checkpoint InhibitorsIBA 05/2023 - 01/2021
5	bisphenol AIBA 04/2022 - 09/2017
5	MicroRNAs (MicroRNA)IBA 04/2022 - 01/2014
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 03/2010
5	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2018
5	Amino Acids FDA Link 01/2015 - 03/2010
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2023 - 10/2019
4	Coal (Coals)IBA 10/2023 - 12/2022
4	Estrogens (Estrogen)FDA Link 01/2022 - 01/2017
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 09/2013
4	Adenosine Diphosphate (ADP)IBA 10/2017 - 01/2011
3	Tyrosine Kinase InhibitorsIBA 03/2023 - 01/2021
3	CytokinesIBA 01/2023 - 01/2020
3	Diethylhexyl Phthalate (DEHP)IBA 01/2022 - 01/2017
3	AlbuminsIBA 05/2021 - 09/2020
3	PlatinumIBA 01/2021 - 12/2011
3	Intercalating AgentsIBA 01/2019 - 09/2010
3	Testosterone (Sustanon)FDA Link 08/2018 - 01/2017
3	imidazo(1,2-a)quinoxaline-2-carboxylic acidIBA 01/2018 - 02/2017
3	Carbolines (Beta-Carbolines)IBA 01/2017 - 09/2010
3	Analgesics (Analgesic Drugs)IBA 01/2015 - 03/2010
3	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2011 - 10/2009
2	5-dimethylaminonaphthalene-1-sulfonamideIBA 03/2022 - 05/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2021
2	C-Reactive ProteinIBA 01/2022 - 01/2022
2	ProstaglandinsIBA 01/2022 - 01/2020
2	AndrogensIBA 01/2022 - 10/2019
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2022 - 01/2017
2	Endocrine DisruptorsIBA 10/2021 - 09/2017
2	Untranslated RNA (Noncoding RNA)IBA 06/2021 - 12/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2017
2	Carbon DioxideIBA 09/2020 - 07/2015
2	Apolipoproteins E (ApoE)IBA 09/2020 - 03/2020
2	ApolipoproteinsIBA 09/2020 - 03/2020
2	GlucocorticoidsIBA 09/2020 - 01/2016
2	arginyl-glycyl-aspartyl-valineIBA 01/2020 - 09/2013
2	Gemcitabine FDA Link 01/2020 - 01/2019
2	BerberineIBA 01/2020 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 01/2017
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2019 - 01/2019
2	Peptides (Polypeptides)IBA 01/2019 - 01/2018
2	dimethyl 2,2'- ((2,2'- (ethane- 1,1- diyl)bis(1H- indole- 3,2- diyl))diacetateIBA 08/2018 - 01/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 01/2017
2	Arachidonic Acid (Vitamin F)IBA 10/2017 - 01/2015
2	Platelet Activating FactorIBA 10/2017 - 01/2015
2	Carboxylic AcidsIBA 09/2017 - 01/2017
2	PyransIBA 09/2017 - 01/2017
2	Nanoparticle Drug Delivery SystemIBA 02/2017 - 09/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2015 - 03/2010
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2012 - 12/2011
2	EstersIBA 08/2011 - 03/2010

Therapy/Procedure

12	Therapeutics 01/2023 - 01/2015
6	Drug Therapy (Chemotherapy) 03/2023 - 01/2015
4	Immunotherapy 05/2023 - 01/2019
2	Radiotherapy 05/2023 - 01/2022